Featured Stories

#Trending

View All

Medical Technologies

View All
lung cancer screening

Lung Cancer Screenings: Raising Rates and Awareness

Lung cancer is the second most common cancer among men and women, and the leading cause of cancer death in the United States. Yet, studies show an alarmingly low rate of participation among those who are eligible for lung cancer screenings.

MedPresence as a telepresence tool for virtual clinical education

Simulation Is About to Get Much More Real

COVID-19-related restrictions on in-class learning have limited access to procedure spaces and created a demand for alternatives such as virtual clinical education. Remote participants such as students, fellows, and mentors need a remote access tool that provides in-room and clinical context video and audio communications—a tool that is much more robust than the typical video teleconference platform. 

Research Round-Up

View All
orbeye exoscope and two doctors

ORBEYE Helps Surgical Teams Protect Against COVID-19

A recent case report published in Otolaryngology-Head and Neck Surgery details how the use of the ORBEYE 4K 3D exoscope allows surgeons to perform otologic surgery with sterile draping and proper PPE without compromising surgical visualization or patient outcomes.

Patient Experience

View All
iTind patient

Jim's iTind™ Experience

Jim has been receiving treatment for enlarged prostate, or benign prostatic hyperplasia, for almost 10 years. For most of that time, he was taking prescription medication, but when the drugs began to lose their effect, Jim and his urologist began discussing other options for treatment.

old man

“Don’t suffer silently.”

Dr. Jed Kaminetsky urged men to take advantage of the BPH treatment options available, including minimally invasive procedures.

At Our Core

View All
Olympus team at previous Tour De Tush Event

A New Spin on the Tour de Tush: National, Virtual, and Goal Attainable

The annual event is in its second virtual year, and Maggie has renewed her 200-mile “Weekend Warrior” goal for the month, which she plans to tackle on both her Trek® road bike and her Peloton® stationary bike. Maggie started racking up her miles on May 1, 2022, the first day of the month-long event.

Endometrial Cancer Awareness Ribbon

True or False? Six Endometrial Cancer Questions Answered

In the U.S., endometrial cancer—cancer in the lining of the uterus--is the most common gynecologic cancer, based on American Cancer Society data. While there is no standard screening test for uterine cancer, we know enough to list some important facts to help women determine if a symptom is concerning enough to get checked out. Try your hand at these true-or-false statements to learn more.

Professionals collaborating on a project

Olympus Sponsors MedTech Color 2022 Pitch Competition

On March 8, 2022, Olympus Corporation of the Americas had the honor of sponsoring a hybrid event featuring live pitches from the top 10 finalists of competing med-tech organizations all with the same goal: to get their early-stage medical technology innovation funded. The MedTech Color 2022 Pitch Competition, an inspired event via MedTech Color, served as a catalyst for early-stage med-tech companies founded or led by persons of color to present their medical innovations for awards ranging from $100K - $250K in non-dilutive funding and in-kind services. 

Inside Olympus

View All
engineering steps

Spotlight on Talent: Scott Pfeifer

The development of single-use bronchoscopes and navigational tools and instruments requires top software talent, and Scott says his team is amazing to work with.

Deanna Gokhman

Calling All Nurses: Opportunities Await in Westborough

The healthcare industry’s unsung heroes pay a high price, but there are opportunities available and companies anxious for everything nurses bring to the table. Just ask Deanna Gokhman, Olympus’ Senior Training Manager for Urology.